Michael R. Minogue - Aug 5, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Signature
/s/ Marc A Began (by power of attorney)
Stock symbol
ABMD
Transactions as of
Aug 5, 2021
Transactions value $
-$7,950,832
Form type
4
Date filed
8/6/2021, 04:16 PM
Previous filing
Jun 23, 2021
Next filing
Aug 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock $.01 par value Options Exercise $579K +25K +11.81% $23.15 237K Aug 5, 2021 Direct F5
transaction ABMD Common Stock $.01 par value Sale -$5.07M -14.9K -6.29% $340.27 222K Aug 5, 2021 Direct F6, F7
transaction ABMD Common Stock $.01 par value Sale -$1.84M -5.38K -2.43% $341.44 216K Aug 5, 2021 Direct F6, F8
transaction ABMD Common Stock $.01 par value Sale -$457K -1.34K -0.62% $342.48 215K Aug 5, 2021 Direct F6, F9
transaction ABMD Common Stock $.01 par value Sale -$515K -1.5K -0.7% $343.32 214K Aug 5, 2021 Direct F6, F10
transaction ABMD Common Stock $.01 par value Sale -$173K -500 -0.23% $345.33 213K Aug 5, 2021 Direct F6, F11
transaction ABMD Common Stock $.01 par value Sale -$138K -400 -0.19% $346.08 213K Aug 5, 2021 Direct F6, F12
transaction ABMD Common Stock $.01 par value Sale -$344K -1K -0.47% $344.43 212K Aug 5, 2021 Direct F6, F13
holding ABMD Common Stock $.01 par value 52.6K Aug 5, 2021 By Trust - A
holding ABMD Common Stock $.01 par value 73.7K Aug 5, 2021 By Trust - B
holding ABMD Common Stock $.01 par value 32.8K Aug 5, 2021 By Trust - C
holding ABMD Common Stock $.01 par value 655 Aug 5, 2021 By Trust - D
holding ABMD Common Stock $.01 par value 38.6K Aug 5, 2021 By Trust - E
holding ABMD Common Stock $.01 par value 85K Aug 5, 2021 By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABMD Stock Option (Right to Buy) Disposed to Issuer $0 -25K -41.67% $0.00 35K Aug 5, 2021 Common stock 25K $23.15 Direct F1, F2, F5
holding ABMD Stock Option (right to buy) 85K Aug 5, 2021 Common Stock 0 $21.55 Direct F2, F3
holding ABMD Stock Option (right to buy) 35K Aug 5, 2021 Common Stock 0 $66.25 Direct F2, F3
holding ABMD Stock Option (right to buy) 30.5K Aug 5, 2021 Common Stock 0 $99.62 Direct F3, F4
holding ABMD Stock Option (right to buy) 33K Aug 5, 2021 Common Stock 0 $134.51 Direct F3, F4
holding ABMD Stock Option (right to buy) 30K Aug 5, 2021 Common Stock 0 $381.97 Direct F3, F4
holding ABMD Stock Option (right to buy) 50K Aug 5, 2021 Common Stock 0 $266.39 Direct F3, F4
holding ABMD Stock Option (Right to Buy) 20.9K Aug 5, 2021 Common Stock 0 $223.90 Direct F3, F4
holding ABMD Stock Option (Right to Buy) 30K Aug 5, 2021 Common Stock 0 $283.88 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F5 Exercise of stock options pursuant to reporting owners 10b5-1 plan.
F6 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F7 This price represents the sale price of the transactions on the reported date at $340.2661. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8 This price represents the sale price of the transactions on the reported date at $341.4448. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9 This price represents the sale price of the transactions on the reported date at $342.4849. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F10 This price represents the sale price of the transactions on the reported date at $3343.3223. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F11 This price represents the sale price of the transactions on the reported date at $345.3314. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F12 This price represents the sale price of the transactions on the reported date at $346.0750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F13 This price represents the sale price of the transactions on the reported date at $344.4270. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.